Intramedullary Nail Market Size, Share & Trends Analysis By Type (Tibial Nail, Femoral Nail, Humeral Nail, Cephalomedullary Nail, Forearm Nail), By Material (Titanium Intramedullary Nail, Stainless Steel IM Nail, Biodegradable IM Nail), By End-Use (Orthopedic Hospital, Trauma Center, Ambulatory Surgical Center, Orthopedic Clinic), By Region, And Segment Forecasts, Market Size, Market Share, and Forecast Analysis, 2026 – 2036

Market Overview

According to Novatrends Market Intelligence, the Global Intramedullary Nail Market was valued at USD 2.44 billion in 2025 and is anticipated to propel at a growth rate of 6.4% from 2026-2036.

The intramedullary nail market encompasses tibial nail, femoral nail, humeral nail, cephalomedullary nail, and forearm nail products in titanium intramedullary nail, stainless steel IM nail, and biodegradable IM nail materials for orthopedic hospitals, trauma centers, ambulatory surgical centers, and orthopedic clinics providing intramedullary fixation of long bone fractures and proximal femur fractures. Intramedullary rod market (intramedullary nail, IM nail, intramedullary fixation implant) covers orthopedic surgical implants inserted into the medullary canal (intramedullary cavity) of a long bone to provide internal fixation of long bone fractures (tibia, femur, humerus, radius, ulna) — the intramedullary nail acts as a load-sharing internal splint within the bone, stabilizing the fracture while preserving blood supply to the fracture site and enabling controlled fracture healing with load-bearing bone. Intramedullary fixation market covers both standard long bone nail fixation and the rapidly growing cephalomedullary nail segment. Femoral intramedullary nail (femoral IM nail, femoral rod, antegrade femoral nail, retrograde femoral nail) is the largest IM nail segment by volume and revenue — used for diaphyseal femur fracture, subtrochanteric femur fracture fixation, and distal femur fracture, inserted antegradely through the piriformis fossa or trochanteric entry portal (antegrade femoral nail) or retrogradely through the intercondylar notch (retrograde femoral nail). Cephalomedullary nail market (short cephalomedullary nail, long cephalomedullary nail, hip fracture nail market, hip nail, InterTAN nail, Gamma nail, PFN nail) is the fastest-growing IM nail segment — cephalomedullary nail provides combined intramedullary femoral shaft fixation with a proximal lag screw or blade element directed into the femoral head and neck for intertrochanteric hip fracture, subtrochanteric fracture, and reverse oblique femur fracture fixation. Hip fracture nail market (intertrochanteric fracture nail, pertrochanteric fracture nail) is driven by aging population fall-related hip fracture incidence growth globally. Tibial intramedullary nail (tibial nail, tibial IM nail, tibial rod) provides intramedullary fixation for tibial shaft diaphyseal fractures, distal tibial fractures, and proximal tibial fractures — the most commonly nailed fracture type globally. Humeral intramedullary nail (humeral nail, antegrade humeral nail, humeral IM nail) provides intramedullary fixation for humeral shaft fractures and proximal humerus fractures. Titanium intramedullary nail is the dominant IM nail material — titanium alloy (Ti-6Al-4V) provides superior biocompatibility, MRI compatibility, and elastic modulus closer to cortical bone than stainless steel, reducing stress shielding. DePuy Synthes Intramedullary Nail (Johnson & Johnson DePuy Synthes, Expert and PFNA nail systems) is the global market leader for femoral nail, tibial nail, and cephalomedullary nail product lines. Stryker Intramedullary Nail (Stryker Trauma, Gamma3 nail, T2 tibial nail, InterTAN nail) is the #2 global IM nail brand — Stryker InterTAN cephalomedullary nail and Stryker Gamma3 hip fracture nail are market-leading cephalomedullary nail designs. Zimmer Biomet Intramedullary Nail (Zimmer Biomet Trauma, Natural Nail system, Sirus nail) and Smith and Nephew IM Nail (Smith & Nephew, Trigen nail system) are major intramedullary fixation market competitors. Nail fixation fracture treatment using IM nails is the standard of care for most long bone diaphyseal fractures and intertrochanteric hip fractures globally. Long bone fracture nail fixation (IM nail for tibia, femur, humerus, forearm) remains the dominant minimally invasive orthopedic fracture fixation method versus open plate fixation. Antegrade femoral nail (piriformis entry nail, trochanteric entry nail) and retrograde femoral nail are the primary IM nail insertion technique variants for femur fracture fixation. Intramedullary nail market size is driven by aging population hip fracture incidence, long bone fracture trauma incidence, and global orthopedic trauma surgical volume growth.

Market Dynamics

The market is driven by aging global population driving hip fracture nail market cephalomedullary nail demand growth — intertrochanteric hip fracture incidence is growing at 3–5% annually globally with aging populations in North America, Europe, Japan, China, and India, each requiring cephalomedullary nail surgical fixation within 48 hours of admission — long bone fracture trauma volume growth in developing countries with expanding road traffic accident (RTA) rates and sports injury volume driving increasing tibial intramedullary nail, femoral intramedullary nail, and humeral intramedullary nail procedure volumes, and global orthopedic trauma surgical upgrade investment with developing country hospitals and trauma centers expanding orthopedic trauma operating room capability and IM nail surgical implant procurement programs. DePuy Synthes intramedullary nail market leadership is maintained through the PFNA cephalomedullary nail, Expert femoral nail, and comprehensive trauma nail product portfolio. Stryker intramedullary nail InterTAN and Gamma3 hip fracture nail designs are validated clinical solutions for cephalomedullary nail procedures. Zimmer Biomet intramedullary nail is growing in the North American and Asian orthopedic trauma markets. Smith and Nephew IM nail Trigen system is expanding in global orthopedic trauma markets. Titanium intramedullary nail adoption is growing globally as the preferred IM nail material. Long bone fracture nail fixation volume is growing with trauma surgery capacity expansion globally. Antegrade femoral nail technique adoption is growing with improved surgical training globally. Nail fixation fracture outcomes data is supporting IM nail versus plate fixation in more fracture patterns. Intramedullary nail market trends show growing cephalomedullary nail, hip fracture nail, and long bone fracture nail demand globally. In January 2024, DePuy Synthes expanded intramedullary nail and cephalomedullary nail with TFNA proximal femoral nail and Expert tibial nail innovations, while Stryker advanced InterTAN nail and Gamma3 cephalomedullary nail for hip fracture nail market. Intramedullary nail market trends show growing cephalomedullary nail, aging population hip fracture, and emerging market trauma nail demand globally through 2036.

Segment Analysis

By Type: Tibial Nail holds the largest share of the Intramedullary Nail market, supported by strong adoption and well-established supply chains across key end-use industries. Femoral Nail is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By Material: Titanium Intramedullary Nail holds the largest share of the Intramedullary Nail market, supported by strong adoption and well-established supply chains across key end-use industries. Stainless Steel IM Nail is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

By End-Use: Orthopedic Hospital holds the largest share of the Intramedullary Nail market, supported by strong adoption and well-established supply chains across key end-use industries. Trauma Center is the fastest-growing segment, propelled by rising investments and expanding application scope in high-growth sectors.

Recent Developments in Intramedullary Nail Market

• In January 2024, DePuy Synthes (Johnson & Johnson MedTech) expanded DePuy Synthes intramedullary nail and cephalomedullary nail with TFNA proximal femoral nail system and Expert tibial nail innovations, advancing femoral intramedullary nail, hip fracture nail market, and intramedullary nail market growth for orthopedic hospital and trauma center long bone fracture fixation programs globally.
• In April 2024, Stryker Corporation (USA) advanced Stryker intramedullary nail and cephalomedullary nail with Stryker InterTAN II nail and Gamma3 hip fracture nail innovations, expanding tibial intramedullary nail, antegrade femoral nail, and intramedullary nail market growth for orthopedic trauma center and ambulatory surgical center fracture fixation programs globally.
• In July 2024, Zimmer Biomet Holdings Inc. (USA) expanded Zimmer Biomet intramedullary nail and titanium intramedullary nail with Zimmer Natural Nail and Sirus femoral nail innovations, advancing nail fixation fracture, long bone fracture nail, and intramedullary nail market growth for orthopedic hospital and trauma center intramedullary fixation market programs globally.
• In September 2024, Smith & Nephew plc (UK) advanced Smith and Nephew IM Nail and intramedullary fixation market with S&N Trigen femoral nail, tibial nail, and humeral intramedullary nail innovations, expanding hip fracture nail market, cephalomedullary nail market, and intramedullary nail market growth for global orthopedic hospital and trauma center nail fixation fracture programs globally.
• In December 2024, Orthofix Medical Inc. (USA) expanded IM nail market and tibial intramedullary nail with Orthofix TFN-ADVANCED tibial nail and fixation system innovations, advancing intramedullary fixation market, long bone fracture nail, and intramedullary nail market growth for North American and global orthopedic trauma center and ambulatory surgical center fracture nail programs globally.
• In March 2025, Medimetal Kft. (Hungary) advanced cephalomedullary nail market and hip fracture nail market with Medimetal PFN and CEN cephalomedullary nail innovations, expanding intramedullary nail market growth, titanium intramedullary nail, and intramedullary fixation market for Eastern European and global orthopedic hospital and trauma center nail fixation programs globally.

Top Intramedullary Nail Market - Key Market Players

• DePuy Synthes (Johnson & Johnson)
• Stryker Corporation
• Zimmer Biomet Holdings Inc.
• Smith & Nephew plc
• Orthofix Medical Inc.
• Medimetal Kft. (Hungary)
• Acumed LLC (USA)
• Biomet Trauma (Zimmer Biomet)
• Globus Medical Inc. (USA)
• Braun Melsungen AG (B. Braun)
• Medtronic plc (Ireland)
• Synthes GmbH (DePuy Synthes)
• Integra LifeSciences (USA)
• Lima Corporate (Italy)
• aap Implantate AG (Germany)

Global Intramedullary Nail Market Report- Scope (Customizable)

Detailed Market Segmentation

• By Type (Revenue in USD Million)
  • Tibial Nail
  • Femoral Nail
  • Humeral Nail
  • Cephalomedullary Nail
  • Forearm Nail
• By Material (Revenue in USD Million)
  • Titanium Intramedullary Nail
  • Stainless Steel IM Nail
  • Biodegradable IM Nail
• By End-Use (Revenue in USD Million)
  • Orthopedic Hospital
  • Trauma Center
  • Ambulatory Surgical Center
  • Orthopedic Clinic
• By Region (Revenue in USD Million)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Russia
    • Italy
    • Spain
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Central & South America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Turkey
    • Egypt
    • South Africa